• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CUE HEALTH INC. CUE COVID-19 TEST FOR HOME AND OVER THE COUNTER (OTC) USE; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CUE HEALTH INC. CUE COVID-19 TEST FOR HOME AND OVER THE COUNTER (OTC) USE; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID Back to Search Results
Model Number C2020
Device Problem False Negative Result (1225)
Patient Problems Viral Infection (2248); Sore Throat (2396)
Event Date 08/06/2022
Event Type  malfunction  
Manufacturer Narrative
Response to device evaluated by manufacturer: cartridges used by the consumer were not sent back for evaluation, therefore, the devices could not be evaluated.The customer provided information regarding the suspected false negative tests and a member of the technical support group was able to perform data analysis.The complaint history was reviewed and there was one similar complaint against involved lot.The lot history record (lhr) was reviewed for the lot number in the complaint, and it passed release specifications.A technical support representative reviewed customer data and performed data analysis.All data values were normal and met acceptable criteria.Root cause was undetermined.
 
Event Description
Customer reported that her daughter received two (2) false negative results using the cue covid-19 test for home and over the counter (otc) use.This report is to document the false negative that occurred (b)(6) 2022.See case-2022-1527-1 for alternate false negative result.Customer reports individual received a false negative result on (b)(6) 2022 when testing with the cue covid-19 test for home and over the counter (otc) use (cartridge sn (b)(4) lot 22008b, reader sn (b)(4).On (b)(6) 2022, customer tested positive with an unspecified brand of at-home test.On (b)(6) 2022, customer tested positive with a binaxnow antigen test and with an indicaid at-home test.On (b)(6) 2022, an additional binaxnow antigen test was performed and a positive result was obtained.Individual has mild symptoms (sore throat).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CUE COVID-19 TEST FOR HOME AND OVER THE COUNTER (OTC) USE
Type of Device
REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
Manufacturer (Section D)
CUE HEALTH INC.
4980 carroll canyon rd
suite 100
san diego CA 92121
Manufacturer Contact
roderick castillo
4980 carroll canyon rd
suite 100
san diego, CA 92121
8332838378
MDR Report Key16410694
MDR Text Key310241646
Report Number3016758165-2023-00368
Device Sequence Number1
Product Code QJR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210180
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 02/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date10/15/2022
Device Model NumberC2020
Device Lot Number22008B
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/06/2022
Initial Date FDA Received02/21/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured01/15/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-